Plain-English translation of NCT07783984 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Atrial Fibrillation research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a surgical procedure performed through small chest incisions (thoracoscopic ablation) works better than a catheter-based procedure (where a thin tube is guided through blood vessels) for treating persistent irregular heartbeats in people with enlarged heart chambers. Both procedures use heat or energy to create scar tissue that helps restore normal heart rhythm. The trial will compare how well each approach works and how safe they are over one year of follow-up.
Persistent atrial fibrillation is harder to treat than other types of irregular heartbeats, especially when the heart chambers are enlarged. While both procedures are used today, doctors aren't sure which one works better for patients with enlarged hearts, so this trial aims to find out.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive either the surgical procedure (thoracoscopic ablation) or the catheter-based procedure (endocardial ablation). After your procedure, you'll have a 3-month recovery period where your heart rhythm may occasionally feel irregular—this is expected. You'll visit the clinic at 3, 6, and 12 months, and then every 6 months, with heart rhythm monitoring using EKGs and portable heart monitors. The study team will track how well your heart rhythm stays normal and whether your symptoms improve over time.
AI-generated summary from trial data · Aug 30, 2026 · Not medical advice
South Korea